549 related articles for article (PubMed ID: 19913804)
1. Contemporary applications and limitations of magnetic resonance imaging contrast materials.
Natalin RA; Prince MR; Grossman ME; Silvers D; Landman J
J Urol; 2010 Jan; 183(1):27-33. PubMed ID: 19913804
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-associated nephrogenic systemic fibrosis.
Schlaudecker JD; Bernheisel CR
Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
[TBL] [Abstract][Full Text] [Related]
3. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K
Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.
Bernstein EJ; Schmidt-Lauber C; Kay J
Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):489-503. PubMed ID: 23040363
[TBL] [Abstract][Full Text] [Related]
5. [Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].
Mundim JS; Lorena Sde C; Abensur H; Elias RM; Moysés RM; Castro MC; Romão Júnior JE
Rev Assoc Med Bras (1992); 2009; 55(2):220-5. PubMed ID: 19488662
[TBL] [Abstract][Full Text] [Related]
6. Nephrogenic Systemic Fibrosis Manifesting a Decade After Exposure to Gadolinium.
Larson KN; Gagnon AL; Darling MD; Patterson JW; Cropley TG
JAMA Dermatol; 2015 Oct; 151(10):1117-20. PubMed ID: 26017458
[TBL] [Abstract][Full Text] [Related]
7. [Nephrogenic fibrosing dermatosis: From clinic to microscopy].
Yoldez H; Ahlem B; Abderrahim E; Faten Z; Soumaya R
Nephrol Ther; 2018 Feb; 14(1):47-49. PubMed ID: 29239786
[TBL] [Abstract][Full Text] [Related]
8. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
Boyd AS; Sanyal S; Abraham JL
J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
[TBL] [Abstract][Full Text] [Related]
9. Pathomechanisms of nephrogenic systemic fibrosis: new insights.
Gupta A; Shamseddin MK; Khaira A
Clin Exp Dermatol; 2011 Oct; 36(7):763-8. PubMed ID: 21790732
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis: a review of the new conundrum.
Goenka AH; Das CJ; Sharma R
Natl Med J India; 2009; 22(6):302-6. PubMed ID: 20384019
[TBL] [Abstract][Full Text] [Related]
11. Application of extracellular gadolinium-based MRI contrast agents and the risk of nephrogenic systemic fibrosis.
Heverhagen JT; Krombach GA; Gizewski E
Rofo; 2014 Jul; 186(7):661-9. PubMed ID: 24477507
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic systemic fibrosis: concepts and perspectives.
Igreja AC; Mesquita Kde C; Cowper SE; Costa IM
An Bras Dermatol; 2012; 87(4):597-607. PubMed ID: 22892775
[TBL] [Abstract][Full Text] [Related]
13. Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.
Foss C; Smith JK; Ortiz L; Hanevold C; Davis L
Pediatr Dermatol; 2009; 26(5):579-82. PubMed ID: 19840315
[TBL] [Abstract][Full Text] [Related]
14. Free gadolinium is a likely trigger of nephrogenic systemic fibrosis.
Abraham JL; Edward M
AJR Am J Roentgenol; 2009 Oct; 193(4):W354; author reply W355. PubMed ID: 19770307
[No Abstract] [Full Text] [Related]
15. Nephrogenic systemic fibrosis: a concise review for cardiologists.
Cheong BY; Muthupillai R
Tex Heart Inst J; 2010; 37(5):508-15. PubMed ID: 20978560
[TBL] [Abstract][Full Text] [Related]
16. Nephrogenic systemic fibrosis: clinical picture and treatment.
Marckmann P; Skov L
Radiol Clin North Am; 2009 Sep; 47(5):833-40, vi. PubMed ID: 19744598
[TBL] [Abstract][Full Text] [Related]
17. Contrast-induced nephropathy and nephrogenic systemic fibrosis: minimizing the risk.
Nicholas BA; Vricella GJ; Smith M; Passalacqua M; Gulani V; Ponsky LE
Can J Urol; 2012 Feb; 19(1):6074-80. PubMed ID: 22316507
[TBL] [Abstract][Full Text] [Related]
18. [Causal relationship between the use of gadolinium based contrast media and nephrogenic systemic fibrosis].
Varela CU; Prieto-Rayo JC
Rev Med Chil; 2014 Dec; 142(12):1565-74. PubMed ID: 25693439
[TBL] [Abstract][Full Text] [Related]
19. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy.
Kribben A; Witzke O; Hillen U; Barkhausen J; Daul AE; Erbel R
J Am Coll Cardiol; 2009 May; 53(18):1621-8. PubMed ID: 19406336
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic systemic fibrosis: is gadolinium to be blamed?
Jikki PN
J Assoc Physicians India; 2008 Nov; 56():915-6. PubMed ID: 19263697
[No Abstract] [Full Text] [Related]
[Next] [New Search]